Thanks, Donald. indie delivered strong second quarter results, once again achieving the top end of our forecast range, exceeding analyst expectations. In fact, Q2 represents our fifth consecutive quarter of outperformance versus plan post indie's IPO last summer. Revenue for the period was up 181% year-over-year and 17% sequentially to a record $25.8 million. Gross profit was $12.5 million, translating into a 48.6% gross margin, up 650 basis points year-over-year and 120 basis points sequentially and above our 48% guidance. Operating expenses were $29.5 million against our outlook for $30 million. R&D investments were $22 million as we accelerated product development, while SG&A of $7.5 million supported our expanded sales reach and the last elements of public company infrastructure including a global ERP system for enhanced scalability. As a result, our operating loss was $17 million. Interest and other expenses yielded $100,000 and taxes were negligible. In turn, our net loss was $16.9 million, with a loss per share of $0.11 on a base of 148.7 million shares, $0.01 better than consensus estimates. Turning to the balance sheet. During the quarter, we invested $4.9 million in working capital, including $2.2 million for inventory, to ensure supply in support of our stronger second half growth plan. And we licensed a key IP block for another $2.2 million. Our capital expenditures were $1.3 million for additional lab equipment and expanded IT infrastructure. Finally, we made $6 million in deferred acquisition-related payments to onsemi and Citi semiconductor exiting the period with $164.1 million in cash. Looking forward, based on our strong order visibility from new products and customer ramps, we expect to continue to substantially outpace indie's addressable markets. Specifically, for the third quarter of 2022, we anticipate top line growth on the order of 140% to 150% year-over-year. At the midpoint of this range, indie will be on a roughly $120 million annualized revenue run rate. And for the first time, we plan to deliver gross margin in the 50% range. We are planning to moderate operating expenses with $23 million in R&D and $8 million of SG&A. Below the line, we anticipate a pickup of $300,000 of net interest income and no taxes. Assuming 149 million shares outstanding, we expect a net loss of $0.11 per share, once again, $0.01 better than consensus expectations. More importantly, given the depth of our design win pipeline, demonstrated scalability and planned operating leverage as our revenue growth and gross margin expansion far outpace our cost structure, we are on track to reach profitability in the second half of next year, marking another key step towards achieving our target model of 60% gross and 30% operating margins by 2025. On that note, I'll turn the call back to Donald for his closing comments.